ReviewNanoscale advances2021
Application of polyoxometalates in photocatalytic degradation of organic pollutants.
Review in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 143 citations in OpenAlex.
- Polyoxometalates in environmental remediation and energy storage.Environmental science. Nano · 2026Review
- Bandgap engineering and enhanced charge separation in Zn-modified BiWScientific reports · 2026Article
- Catalytic Performance of Flexible Polycationic Membrane Derived from Polyacrylonitrile for Advanced Applications.Molecules (Basel, Switzerland) · 2026Article
- ZIF-8/graphene composite for photocatalytic degradation under low intensity UV irradiation and antibacterial applications.Scientific reports · 2025Article
- Thermally-driven interface engineering of PMoRSC advances · 2025Article
- A New [PMoMolecules (Basel, Switzerland) · 2025Article
- Study on the performance and mechanism of a p-n type InRSC advances · 2025Article
- Three New Multifunctional Supramolecular Compounds Based on Keggin-Type Polyoxoanions and 3,5-di(1H-Imidazol-1-yl)benzoic Acid: Syntheses, Structures, and Properties.Molecules (Basel, Switzerland) · 2025Article
- Electrochromic polyoxometalates for sensing abiotic stress in plants.Frontiers in plant science · 2025Article
- A review of metal-organic framework (MOF) materials as an effective photocatalyst for degradation of organic pollutants.Nanoscale advances · 2023Review
- Advances in Polyoxometalates as Electron Mediators for Photocatalytic Dye Degradation.International journal of molecular sciences · 2023Review
- Article
- Two New Compounds Based on Bi-Capped Keggin Polyoxoanions and Cu-Bpy Cations Contain Both CuMolecules (Basel, Switzerland) · 2023Article
- Article
- Multicomponent Composite Membrane with Three-Phase Interface Heterostructure as Photocatalyst for Organic Dye Removal.ACS omega · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organic pollutants are highly toxic, accumulative, and difficult to degrade or eliminate. As a low-cost, high-efficiency and energy-saving environmental purification technology, photocatalytic technology has shown great advantages in solving increasingly serious environmental pollution problems. The development of efficient and durable photocatalysts for the degradation of organic pollutants is the key to the extensive application of photocatalysis technology. Polyoxometalates (POMs) are a kind of discrete metal-oxide clusters with unique photo/electric properties which have shown promising applications in photocatalytic degradation. This review summarizes the recent advances in the design and synthesis of POM-based photocatalysts, as well as their application in the degradation of organic dyes, pesticides and other pollutants. In-depth perspective views are also proposed in this review.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.